Upstream Bio (UPB) Receivables (2023 - 2026)
Upstream Bio (UPB) posted quarterly Receivables of $2.6 million for Q1 2026, up 50.0% year-over-year from $1.7 million in Q1 2025, and up 12.32% quarter-over-quarter from $2.3 million in Q4 2025.
Upstream Bio (UPB) Receivables (2023 - 2026) Analysis & Trends
Upstream Bio's Receivables history runs 4 years deep, the most recent figure standing at $2.6 million for Q1 2026.
- In Q1 2026, Receivables rose 50.0% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (up 50.0% YoY), while the FY2025 annual figure was $2.3 million, up 96.69% from the prior year.
- Receivables for Q1 2026 stood at $2.6 million, up from $2.3 million in the prior quarter.
- The five-year high for Receivables was $2.6 million in Q2 2025, with the low at $236000.0 in Q4 2023.
- The 4-year median for Receivables is $1.7 million (2025), against an average of $1.6 million.
- The sharpest annual moves came in 2024 and 2026: Receivables surged 400.0% in 2024, then soared 50.0% in 2026.
- Upstream Bio's Receivables stood at $236000.0 in 2023, then soared by 400.0% to $1.2 million in 2024, then surged by 96.69% to $2.3 million in 2025, then gained by 12.32% to $2.6 million in 2026.
- Business Quant data shows UPB's Receivables at $2.6 million in Q1 2026, $2.3 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Upstream Bio | 387.23 Mn | 387.23 Mn | -3.29 Mn | 2.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.15 Mn |
| Mar 31, 2026 | 2.61 Mn |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 2.64 Mn |
| Mar 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Dec 31, 2023 | 236,000.00 |
| Sep 30, 2023 | 300,000.00 |